Skip to search formSkip to main contentSkip to account menu

Infergen

Known as: Inferax 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

interferon alfacon-1

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
INFERGEN (Interferon Alpha) Infergen (Interferon Alfacon-1) Injection Intron A (Interferon Alfa-2a) Injection
2016
2016
Infergen Stimulated Macrophages Restrict Mycobacterium tuberculosis Growth by Autophagy and Release of Nitric Oxide
IFN alfacon-1 (Infergen) is a synthetic form of Interferon (IFN)-α2b. Infergen has immunomodulatory activity and is effective… 
2015
2015
[Effect of Recombinant Super-compound Interferon (rSIFN-co) on Proliferation and Apoptosis of Human Pulmonary Adenocarcinoma Cell A549].
OBJECTIVE To investigate the effect of recombinant super-compound interferon (rSIFN-co) on the proliferation and apoptosis of… 
2010
2010
[Effect of recombinant super-compound interferon (rSIFN-co) on human breast cancer cells in vitro].
OBJECTIVE To study the anti-cancer activities of recombinant super-compound interferon (rSIFN-co) against human breast cancer… 
2008
2008
[Study on the susceptibility of the cervical carcinoma cells to CTL lysis under the stimulation of rSIFN-co and its mechanism].
OBJECTIVE To investigate the susceptibility of cervical carcinoma cells (HPV16+) to CTL lysis affected by rSIFN-co, consensus… 
2006
2006
Cyto‐reduction of neuroendocrine tumours using Sandostatin LAR® in combination with Infergen®: results of a case series
Historically, limited trials evaluating biotherapy in treating metastatic neuroendocrine tumours have yielded mixed results. In… 
2003
2003
The safety and tolerability of daily infergen plus ribavirin in the treatment of naíïve chronic hepatitis C patients
summary.  The treatment of chronic hepatitis C patients was enhanced when the combination of interferon alfa‐2b and ribavirin was… 
2001
2001
A multi-center randomized trial to determine the safety and tolerability of combination treatment with ribavirin and Infergen for HCV in naive patients
2000
2000
Interferon alfacon-1 (Infergen®) 15 mcg in the treatment of naive chronic hepatitis C patients, three vs. five times a week
2000
2000
Daily induction therapy followed by every other day dosing with Infergen® for HCV patients naive to interferon therapy
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)